NCT06376175

Brief Summary

Healthy volunteers ages 25-40 from the general US population who meet the eligibility criteria and are enrolled will (a) play Lumosity games at least 20 times each in under 60 days and (b) then complete one session of task-based functional magnetic resonance imaging (fMRI) while playing Lumosity games.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 19, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

April 24, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2025

Completed
Last Updated

January 31, 2025

Status Verified

January 1, 2025

Enrollment Period

8 months

First QC Date

April 3, 2024

Last Update Submit

January 29, 2025

Conditions

Keywords

cognitionfMRI

Outcome Measures

Primary Outcomes (8)

  • BOLD response during gameplay

    Whole-brain blood oxygen level-dependent (BOLD) response during gameplay

    Day 60

  • Responder rates

    Percentage of participants who show A) BOLD response by brain region during gameplay, B) Between-network connectivity, based on BOLD responses, during gameplay, C) Within-network connectivity, based on BOLD responses, during gameplay

    Day 60

  • Structural MRI volumetrics: Volume

    Volume at rest

    Day 60

  • Structural MRI volumetrics: Cortical thickness

    Cortical thickness measured in millimeters

    Day 60

  • Structural MRI volumetrics: Brain-Predicted Age Difference

    Brain-Predicted Age Difference at rest

    Day 60

  • Behavior response: Game score

    Score on game after completion of gameplay

    Day 60

  • BAMS-7 (Brief Attention and Mood Scale of 7 Items)

    Subject-reported BAMS-7 (Brief Attention and Mood Scale of 7 Items) including the Attention subscale, Mood subscale, and Total, measured post-imaging

    Day 60

  • VGPQ (Video Game Playing Questionnaire)

    Subject-reported VGPQ (Video Game Playing Questionnaire) including non-video game playing (NVGP) and video game playing (VGP)

    Day 60

Eligibility Criteria

Age25 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy adults age 25-40

You may qualify if:

  • Subjects 25-40 years of age.
  • Ability to understand and speak English, follow written and verbal instructions (English), and give informed consent (English), as assessed by the PI or project manager.
  • Ability to comply with all the testing and study requirements, including the ability to independently complete daily, online Lumosity games on a reliable, internet-connected device.
  • Geographical location within 100 miles of the study imaging center.

You may not qualify if:

  • Current, controlled (requiring treatment) or uncontrolled psychiatric diagnosis, including but not limited to posttraumatic stress disorder, psychosis, bipolar illness, pervasive developmental disorder, severe obsessive compulsive disorder, severe depressive or severe anxiety disorder, conduct disorder, attention- deficit/hyperactivity disorder, or other symptomatic manifestations that in the opinion of the PI may confound study data/assessments.
  • Current, controlled (requiring treatment) or uncontrolled neurological diagnosis, including but not limited to Alzheimer's Disease, other dementias, mild cognitive impairment, Huntington's Disease, Parkinson's Disease, multiple sclerosis, stroke, epilepsy, aphasia, or other condition that in the opinion of the PI may confound study data/assessments.
  • Any other medical condition in the last 90 days that in the opinion of the PI may confound study data/assessments.
  • Has been under the care of a caretaker or has not been living independently in the last 90 days.
  • In the last three years has used online brain training programs (e.g., BrainHQ, Lumosity, Peak) for more than two weeks continuously.
  • Known sensitivity (such as headaches, dizziness, nausea) to bright, stimulating video displays.
  • History of seizures (excluding febrile seizures), or significant motor or vocal tics, including but not limited to Tourette's Disorder and photo-sensitive epilepsy.
  • Visual acuity that cannot be corrected that prevents or negatively impacts computer activity.
  • Pregnancy, or strong likelihood of pregnancy.
  • Left-handed or ambidextrous.
  • Unwillingness or inability to comply with imaging safety protocols. Inability includes but is not limited to metal implants or exposure to shrapnel.
  • Any other condition that in the opinion of the PI may confound study data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UC Davis Imaging Research Center (IRC)

Sacramento, California, 95817, United States

Location

Study Officials

  • Kevin Madore, PhD

    Lumos Labs, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2024

First Posted

April 19, 2024

Study Start

April 24, 2024

Primary Completion

December 15, 2024

Study Completion

January 15, 2025

Last Updated

January 31, 2025

Record last verified: 2025-01

Locations